Lipo-C: Variable Lipotropic Injection Formulas and Dose References
On this page
Quick Reference Card
Attribute
Identity
Attribute
Formula variability
Attribute
Component evidence
Attribute
Labeled injection contrast
Attribute
Main dosing issue
- Research reference
- Millilitres are not comparable unless the exact per-mL amounts are known. A “1 mL Lipo-C” entry can mean different amounts of methionine, inositol, choline, carnitine or B12.
Attribute
Doserly tracking angle
- Research reference
- Records need ingredient list, per-mL composition, vial label, route, schedule, source URL, adverse effects and labs kept together.
Quick dose reference
Lipo-C has no standardized approved formula or dose. Volume only makes sense with the exact formula and concentration shown. Any dosing protocol should be reviewed with a qualified healthcare practitioner.
Intramuscular or subcutaneous injection; MIC 25/50/50 mg/mL
Online sourced dosing details
- Reported amount
- 1 mL
- Frequency
- 2–3 times weekly
- Duration
- Not stated
- Dose adjustment
- No escalation schedule specified
- Reported range & limits
- Same formula source reports 1 mL standard and 2 mL higher intramuscular-only use. mL limits are formula-specific; no approved safe upper limit is established.
Evidence and range contextReview the full source references below.
PeptideDosing standard MIC schedule
This row is useful because the per-mL formula is visible; it remains a public protocol, not an approved label.
Other Lipo-C pages add B12, carnitine, or dexpanthenol, so mL volumes are not interchangeable across formulas. The selected standard row is 1 mL, 2–3 times weekly, intramuscular or subcutaneous. The source’s separate higher-volume 2 mL row specifies intramuscular. Its 30-day compounded-vial storage limit is not a treatment duration.
Intramuscular injection; MIC + carnitine 25/50/50/100 mg/mL
Online sourced dosing details
- Reported amount
- 1 mL
- Frequency
- Once weekly
- Duration
- First 4 weeks
- Dose adjustment
- Reassess after week 4
- Reported range & limits
- TrimRX reports 0.5–2 mL intramuscular alternatives around a 1 mL weekly start. Formula-specific volumes are not interchangeable; no approved safe upper limit is established.
Evidence and range contextReview the full source references below.
TrimRX MIC + L-carnitine starting schedule
This named clinic formula shows how adding carnitine changes the meaning of the same mL volume.
CareVibe lists B12 100 mcg/mL and L-carnitine 100 mg with twice-weekly frequency but does not give full MIC per-mL amounts; it is not merged here. Its starting example is 1 mL weekly for four weeks; its 0.5–2 mL alternatives and maintenance intervals describe different scenarios. The site’s broader efficacy claims are not established by this dosing reference.
Full Dosing Reference SourcesClinical research, registered studies and online dosing sources, with their context and limitations.
For Lipo-C, amount means volume only after formula and concentration are known.
Additional sources cited in the summary
PeptideDosing.info Lipo-C page
Typical dose 1-2 mL per injection, intramuscular preferred or subcutaneous, 2-3 times weekly; typical per mL: methionine 25 mg, inositol 50 mg, choline 50 mg [1].
- Evidence limits
- Public protocol page; warns exact per-mL composition varies by compounding pharmacy.
DosagePeptide Lipo-C 10 mL page
Describes Lipo-C as MIC plus B12; clinic references roughly 0.5-1 mL intramuscular, often once or twice weekly [2].
- Evidence limits
- Public dosing page with reconstitution/procedure content; useful for claim attribution only.
TrimRX Lipo-C guide
Claims common per mL formula: methionine 25 mg, inositol 50 mg, choline 50 mg, L-carnitine 100 mg; lists 0.5-2 mL once or twice weekly [3].
- Evidence limits
- Clinic/marketing guide. Claims controlled-trial boundaries but no single standard formula applies.
CareVibe MICC/Lipo-C page
Lists Lipo C ingredients as MIC, B12 100 mcg/mL and L-carnitine 100 mg; frequency twice weekly [4].
- Evidence limits
- Clinic service page; composition line omits full per-mL MIC amounts.
Research Dosing Lipo-C page
Lists methionine, choline chloride, L-carnitine and dexpanthenol; standard protocol says 50-100 units once daily, 2-3 days/week, but expresses 500-1,000 mcg, creating unit ambiguity [12].
- Evidence limits
- Public protocol page; “units” and “mcg” conflict with typical mL nutrient-injection framing.
NIH ODS choline fact sheet
Adequate intake 550 mg/day for adult men and 425 mg/day for adult women; adult upper limit 3,500 mg/day [5].
- Evidence limits
- Nutrition reference; does not validate injectable Lipo-C for fat loss.
NIH ODS carnitine fact sheet
Dietary/supplement context; weight-loss trials are mixed, with a meta-analysis average 1.33 kg more loss than placebo in varied oral trials [6].
- Evidence limits
- Mostly oral supplement evidence and deficiency context; not a Lipo-C injection trial.
DailyMed levocarnitine injection
Labeled intravenous use for inborn errors causing secondary carnitine deficiency and ESRD dialysis deficiency; example ESRD dosing 10-20 mg/kg after dialysis [10].
- Evidence limits
- Prescription deficiency label; not wellness Lipo-C or intramuscular lipotropic dosing.
DailyMed cyanocobalamin injection
1,000 mcg/mL product; pernicious anemia regimen begins with 100 mcg daily for 6-7 days, then tapering and monthly maintenance [11].
- Evidence limits
- Prescription B12 deficiency label; not proof that Lipo-C causes weight loss.
16 Lipo-C sources were included. Meaningful evidence is product/formula-specific public dosing plus ingredient labels/fact sheets; no single approved Lipo-C formula, maximum dose or fat-loss regimen was found.
Applicable product labels and human studies carry the most weight. A registry entry does not establish study results. Animal studies, public guides and forums add context; they do not establish a safe human dose limit.
Official product and regulatory sources
- Levocarnitine injection label
DailyMed / FDA · Background context
Levocarnitine injection label is for deficiency-related prescription use, not compounded Lipo-C wellness formulas.
- Cyanocobalamin injection label
DailyMed / FDA · Background context
Cyanocobalamin label states 1,000 mcg/mL for intramuscular or subcutaneous injection, supporting B12 ingredient context separately from Lipo-C blends.
Human clinical research
- The impact of choline supplementation on oxidative stress and clinical outcomes among patients with non-alcoholic fatty liver disease: a randomized controlled study.
Therapeutic advances in chronic disease · 2025 · Abstract reviewed · Background context
NAFLD study used phosphatidylcholine 2400 mg/day orally for 12 weeks; route and product differ from Lipo-C injections.
Published evidence reviews
- Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis.
Clinical nutrition ESPEN · 2020 · Abstract reviewed · Background context
Oral/supplement L-carnitine meta-analysis found modest body-weight effects around 2 g/day; it does not validate injected Lipo-C blends.
- Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes.
Advances in nutrition (Bethesda, Md.) · 2016 · Abstract reviewed · Background context
Choline/NAFLD review supports biological ingredient context and individualized requirements, not Lipo-C injection dosing.
Clinical reference resources
- Choline fact sheet for health professionals
NIH Office of Dietary Supplements · Background context
NIH choline fact sheet supports ingredient nutrition context but does not validate injected MIC fat-loss protocols.
- Carnitine fact sheet for health professionals
NIH Office of Dietary Supplements · Background context
NIH carnitine fact sheet supports ingredient context and deficiency/medical-use distinctions, not Lipo-C dosing.
- Dietary supplements for weight loss fact sheet for health professionals
NIH Office of Dietary Supplements · Background context
NIH weight-loss supplement fact sheet provides independent context that supplement ingredients do not equal proven injectable fat-loss therapy.
- Vitamin B12 fact sheet for health professionals
NIH Office of Dietary Supplements · Background context
NIH B12 fact sheet supports cyanocobalamin ingredient context when Lipo-C formulas include B12.
- Riboflavin fact sheet for health professionals
NIH Office of Dietary Supplements · Background context
NIH riboflavin fact sheet supports ingredient context for broader lipotropic mixtures, not product dosing.
Public dosing guides and calculators
- Lipo-C protocol
PeptideDosing.info
Public source reports typical 1 mL injections 2–3 times weekly, intramuscular preferred or subcutaneous, and per-mL MIC plus L-carnitine amounts.
- Lipo-C 10 mL vial dosage protocol
DosagePeptide · Background context
Public protocol reports roughly 0.5–1 mL intramuscular once or twice weekly and a MIC+B12-style representative formula.
- Lipo C dosage for lipotropic shot medical injection guide
TrimRX
Clinic guide reports 1 mL intramuscular weekly for the first 4 weeks and formula-specific MIC plus L-carnitine amounts.
- MICC/lipotropic injections
CareVibe Healthcare · Background context
Clinic page supplies another formula example, reinforcing that Lipo-C composition and route are clinic/product-specific.
- Lipo-C dosing protocol
Research Dosing · Background context
Public page reports intramuscular Lipo-C schedules with unit-based dosing; unit ambiguity prevents pooling with mL formulas.
- Lipo-C injection dosage guide
Peptide Clarify · Background context
Public guide reports 1 mL intramuscular 1–2 times weekly; composition may differ from selected formulas.
Pathway visualization

The image treats Lipo-C as a label-dependent category: public formula pages vary, NIH component factsheets and prescription injection labels describe ingredients in their own contexts, and none of those sources establish a single Lipo-C fat-loss pathway [1][2][3][4][5][6][10][11].
What Lipo-C is
Lipo-C is best understood as a variable compounded nutrient-injection category. It is not a peptide and not a single active pharmaceutical ingredient. The “C” often points to L-carnitine, while many pages frame the base as MIC: methionine, inositol and choline [1][2][3][4].
That category framing matters because a blend name does not define a dose. Two products can both say Lipo-C while containing different amounts of methionine, inositol, choline, carnitine, cyanocobalamin, methylcobalamin or dexpanthenol.
Ingredient evidence is component evidence
Choline is an essential nutrient involved in phosphatidylcholine synthesis, lipid transport and cell membranes. NIH notes adequate intake values and upper limits, and it describes liver effects from deficiency [5]. That does not mean injectable choline mixtures cause fat loss.
Carnitine transports long-chain fatty acids into mitochondria. NIH describes mixed weight-loss evidence for supplements and emphasizes that healthy people synthesize sufficient carnitine under normal conditions [6]. DailyMed levocarnitine injection is labeled for deficiency-related medical contexts, including certain metabolic disorders and ESRD dialysis deficiency [10]. That label is not a wellness Lipo-C protocol.
Vitamin B12 and riboflavin factsheets support nutrient-deficiency and dietary context [8][9]. Cyanocobalamin injection is labeled for B12 deficiency states such as pernicious anemia [11]. Those labels do not establish a multi-ingredient lipotropic blend as a body-composition therapy.
Where public Lipo-C sources conflict
The public pages disagree in three practical ways. First, formula: some pages use MIC plus L-carnitine, some use MIC plus B12, some add B5/dexpanthenol, and some leave MIC amounts unspecified [1][2][3][4][12]. Second, units: some sources use mL per injection, while Research Dosing expresses units and micrograms in a way that does not map cleanly to nutrient concentrations [12]. Third, schedule: pages range from once weekly to 3-5 days per week [1][2][3][4][12].
Those contradictions make any universal “Lipo-C dose” misleading. The source row, vial label and per-mL composition are the minimum usable record.
What Doserly helps track
Doserly can keep Lipo-C entries anchored to the actual formula rather than the category name. Useful fields include per-mL ingredient amounts, total volume, route, frequency, clinic or compounder, lot, B12 form, L-carnitine amount, symptoms, injection-site reactions, sleep effects, GI effects and any labs such as B12, homocysteine, liver enzymes or carnitine markers when available.
Academy discussion can separate nutrition factsheets, prescription nutrient-injection labels, clinic Lipo-C pages and public calculator claims without turning them into one protocol.
FAQ
Is Lipo-C a peptide?
No. It is a lipotropic nutrient-injection category, usually involving amino-acid/nutrient components rather than a peptide sequence.
Does 1 mL mean the same thing across Lipo-C products?
No. A millilitre only has meaning when the per-mL formula is known. Public sources list different ingredients and concentrations [1][2][3][4][12].
Do carnitine or choline factsheets prove Lipo-C fat loss?
No. They explain nutrient biology and some component evidence [5][6]. They do not prove that a compounded blend causes clinically meaningful fat loss.
Why include prescription levocarnitine and cyanocobalamin labels?
They show labeled medical contexts for injectable nutrient products [10][11]. Those labels also demonstrate that deficiency treatment is a different evidence category from wellness lipotropic injections.
References
[1] PeptideDosing.info: Lipo-C protocol.
[2] DosagePeptide: Lipo-C 10 mL vial dosage protocol.
[3] TrimRX: Lipo C dosage for lipotropic shot.
[4] CareVibe: MICC/Lipotropic injections.
[5] NIH ODS: Choline fact sheet for health professionals.
[6] NIH ODS: Carnitine fact sheet for health professionals.
[7] NIH ODS: Dietary supplements for weight loss.
[8] NIH ODS: Vitamin B12 fact sheet for health professionals.
[9] NIH ODS: Riboflavin fact sheet for health professionals.
[10] DailyMed: Levocarnitine injection label.
[11] DailyMed: Cyanocobalamin injection label.